CANCER, GENOMICS AND CONSULTING LTD

Executive Summary

Cancer, Genomics and Consulting Ltd is a promising micro-sized enterprise leveraging a unique combination of medical, biotechnological, and IT consulting expertise to address emerging needs in precision oncology. Its strong financial footing and strategic location underpin growth potential through service expansion and partnerships, though scaling operational capacity and managing regulatory complexities remain critical challenges to ensure sustainable competitive advantage.

View Full Analysis Report →
Financials
Year ending
2024-06-30
Total net assets
£53.99k
£39.10k vs previous year
Total liabilities
£-9.17k
£-4.91k vs previous year
Total assets
£64.16k
£44.00k vs previous year

Annual accounts

Financial Year Ending
22 July 2024

View Document

30 June 2024

View Accounts

16 August 2023

View Document

30 June 2023

View Accounts

30 June 2022

View Accounts


More Company Information